U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
156121156121The Effect of Altering Colonic Microflora After Fiber (FOS) ConsumptionCompletedNo Results AvailableHyperlipidemia|Cardiovascular Disease|Diet TherapyProcedure: Diet with polyfructans and viscous fibers or soy proteinhttps://ClinicalTrials.gov/show/NCT00516594
156122156122Occurrence of Pneumocystis Pneumonia in HIV-Infected Patients and the Interference of the HAARTCompletedNo Results AvailableHIVhttps://ClinicalTrials.gov/show/NCT00516581
156123156123EBIS: The Eindhoven Breech Intervention StudyCompletedNo Results AvailableBreech Presentation|External Cephalic Version|Thyroid Hormones|Stress, Psychological|Congenital Hip Dysplasiahttps://ClinicalTrials.gov/show/NCT00516555
156124156124Dehydroepiandrosterone (DHEA) and Letrozole in Treating Patients With Metastatic Breast CancerTerminatedNo Results AvailableBreast CancerDrug: letrozole|Drug: DHEA|Other: pharmacological studyhttps://ClinicalTrials.gov/show/NCT00516542
156125156125Oral Carnitine for Cramps in PregnancyNot yet recruitingNo Results AvailableMuscle CrampDietary Supplement: L-Carnitine|Dietary Supplement: Placebohttps://ClinicalTrials.gov/show/NCT00516516
156126156126Baclofen-Amitriptyline Hydrochloride-Ketamine Gel in Treating Peripheral Neuropathy Caused by Chemotherapy in Patients With CancerCompletedNo Results AvailableChronic Myeloproliferative Disorders|Leukemia|Lymphoma|Lymphoproliferative Disorder|Multiple Myeloma and Plasma Cell Neoplasm|Myelodysplastic Syndromes|Myelodysplastic/Myeloproliferative Neoplasms|Neurotoxicity|Pain|Unspecified Adult Solid Tumor, ProtocolDrug: baclofen/amitriptyline/ketamine gel|Other: placebohttps://ClinicalTrials.gov/show/NCT00516503
156127156127GnRH Agonist Administration in the Luteal Phase of ICSI-ET CyclesCompletedNo Results AvailableInfertilityDrug: triptorelin acetate|Drug: Na Cl %0.9https://ClinicalTrials.gov/show/NCT00516490
156128156128Safety Study in Subjects With Leber Congenital AmaurosisActive, not recruitingNo Results AvailableLeber Congenital AmaurosisBiological: AAV2-hRPE65v2https://ClinicalTrials.gov/show/NCT00516477
156129156129Evaluation of Ranibizumab in Proliferative Diabetic Retinopathy (PDR) Requiring VitrectomyRecruitingNo Results AvailableProliferative Diabetic RetinopathyDrug: Lucentis (ranibizumab)https://ClinicalTrials.gov/show/NCT00516464
156130156130Phase I Study of BMS-690514 in Japanese Patients With Solid TumorsCompletedNo Results AvailableCancerDrug: BMS-690514https://ClinicalTrials.gov/show/NCT00516451
156131156131Study to Assess the Safety and Tolerability of a PARP Inhibitor in Combination With TopotecanCompletedNo Results AvailableMalignant Solid TumorsDrug: KU-0059436 (AZD2281)(PARP inhibitor)|Drug: Topotecanhttps://ClinicalTrials.gov/show/NCT00516438
156132156132Doxorubicin or Epirubicin and Cyclophosphamide in Treating Older Women With Invasive Breast CancerRecruitingNo Results AvailableBreast CancerBiological: pegfilgrastim|Drug: cyclophosphamide|Drug: doxorubicin hydrochloride|Drug: epirubicin hydrochloride|Genetic: proteomic profiling|Other: diagnostic laboratory biomarker analysis|Other: matrix-assisted laser desorption/ionization time of flight mass spectrometry|Other: pharmacological study|Other: surface-enhanced laser desorption/ionization-time of flight mass spectrometry|Procedure: adjuvant therapyhttps://ClinicalTrials.gov/show/NCT00516425
156133156133Everolimus in Treating Patients With Relapsed or Refractory Mantle Cell LymphomaCompletedNo Results AvailableLymphomaDrug: everolimus|Genetic: molecular response by PCRhttps://ClinicalTrials.gov/show/NCT00516412
156134156134A Clinical Trial of the Treatment of Fungal Corneal Ulcers With Povidone-IodineTerminatedNo Results AvailableFungal KeratitisDrug: povidone-iodine 1.25% ophthalmic solution|Drug: natamycin ophthalmic suspension, USP 5%https://ClinicalTrials.gov/show/NCT00516399
156135156135Safety Profile of Insulin Like Growth Factor-1 (IGF-I) Administration in AdolescentsCompletedHas ResultsAnorexia NervosaDrug: RhIGF-1https://ClinicalTrials.gov/show/NCT00516386
156136156136A Study to Assess the Safety and Pharmacokinetics of an Inhibitor of Poly ADP-Ribose Polymerase-1 (PARP)Active, not recruitingNo Results AvailableOvarian Neoplasms|BRCA1 Protein|BRCA2 ProteinDrug: KU-0059436 (AZD2281)(PARP inhibitor)https://ClinicalTrials.gov/show/NCT00516373
156137156137Study of Chlorhexidine as the Hub Antiseptic to Prevent Catheter Related Infections in Newborn InfantsRecruitingNo Results AvailableCatheterizationDevice: 3.15% chlorhexidine as daily antiseptic on needleless access porthttps://ClinicalTrials.gov/show/NCT00516360
156138156138Studying Genes for Barrett's Esophagus in Brothers and SistersRecruitingNo Results AvailableEsophageal Cancer|Precancerous ConditionGenetic: comparative genomic hybridization|Genetic: genetic linkage analysis|Other: laboratory biomarker analysis|Other: questionnaire administration|Procedure: study of high risk factorshttps://ClinicalTrials.gov/show/NCT00516347
156139156139Study of Bedside EEG to Evaluate Brain Injury in Premature NewbornsActive, not recruitingNo Results AvailableBrain Injury|Seizures|Cerebral Palsyhttps://ClinicalTrials.gov/show/NCT00516334
156140156140Eltrombopag To Initiate And Maintain Interferon Antiviral Treatment To Subjects With Hepatitis C Related Liver DiseaseCompletedHas ResultsHepatitis C, ChronicDrug: eltrombopag|Drug: placebohttps://ClinicalTrials.gov/show/NCT00516321
156141156141A Non-Randomized Study of the NightHawk Peripheral Plaque Excision System During Plaque Excision of Peripheral Arterial DiseaseTerminatedNo Results AvailablePeripheral Vascular DiseasesDevice: NightHawkhttps://ClinicalTrials.gov/show/NCT00516308
156142156142Vincristine Sulfate, Topotecan Hydrochloride, and Cyclophosphamide With or Without Bevacizumab in Treating Young Patients With Refractory or First Recurrent Extracranial Ewing SarcomaCompletedHas ResultsEwing Sarcoma of Bone|Extraosseous Ewing Sarcoma|Peripheral Primitive Neuroectodermal Tumor|Recurrent Ewing Sarcoma/Peripheral Primitive Neuroectodermal TumorDrug: topotecan hydrochloride|Drug: vincristine sulfate|Drug: cyclophosphamide|Biological: bevacizumabhttps://ClinicalTrials.gov/show/NCT00516295
156143156143VNP40101M and Temozolomide in Treating Patients With Progressive or Relapsed Malignant GliomaTerminatedNo Results AvailableBrain and Central Nervous System TumorsDrug: CLORETAZINE|Drug: temozolomidehttps://ClinicalTrials.gov/show/NCT00516282
156144156144Methylphenidate Study in Breast or Gastrointestinal Cancer PatientsTerminatedHas ResultsBreast Cancer|Fatigue|Gastrointestinal CancerDrug: Methylphenidate|Drug: Placebohttps://ClinicalTrials.gov/show/NCT00516269
156145156145CHESS: Human and Computer Mentors for Prostate Cancer PatientsActive, not recruitingNo Results AvailableProstate CancerBehavioral: CHESS System|Behavioral: Cancer Information Mentorhttps://ClinicalTrials.gov/show/NCT00516256
156146156146Defined Green Tea Catechin Extract in Treating Women With Hormone Receptor Negative Stage I-III Breast CancerCompletedNo Results AvailableEstrogen Receptor-negative Breast Cancer|Progesterone Receptor-negative Breast Cancer|Stage I Breast Cancer|Stage II Breast Cancer|Stage IIIA Breast Cancer|Stage IIIB Breast CancerOther: placebo|Other: quality-of-life assessment|Procedure: questionnaire administration|Procedure: laboratory biomarker analysis|Drug: defined green tea catechin extracthttps://ClinicalTrials.gov/show/NCT00516243
156147156147Establishing Effective Screening Methods for Diagnosing Hereditary Nonpolypoisis Colorectal CancerRecruitingNo Results AvailableColonic Neoplasmshttps://ClinicalTrials.gov/show/NCT00516230
156148156148Galiximab in Treating Patients With Relapsed or Refractory Hodgkin's LymphomaCompletedHas ResultsLymphomaBiological: galiximabhttps://ClinicalTrials.gov/show/NCT00516217
156149156149Diabetic Under 70 (Diabetics Below 70)CompletedNo Results AvailableDiabetes|Hyperlipidemia|Atherosclerosishttps://ClinicalTrials.gov/show/NCT00516204
156150156150A Phase I/II Study of Liposomal Doxorubicin (Doxil)/Melphalan/Bortezomib (Velcade) in Relapsed/Refractory Multiple MyelomaWithdrawnNo Results AvailableMultiple MyelomaDrug: Liposomal Doxorubicin/Melphalan/Bortezomibhttps://ClinicalTrials.gov/show/NCT00516191

* Görseller ve İçerik tekif hakkına sahip olabilir